Study of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
The purpose of this trial is to compare the effects of TAS-102 and best supportive care (BSC) with Placebo (an inactive drug) and best supportive care on metastatic gastric cancer.
Epistemonikos ID: c73d7c52c9b3a02228f45011217a84ed49b63eb6
First added on: May 12, 2024